Related Experiment Video
Updated: May 11, 2026

08:15
3D Planning and Printing of Patient Specific Implants for Reconstruction of Bony Defects
Published on: August 4, 2020
6.4K
Perspectives on 3D printed personalized medicines for pediatrics
Haixu Tong1, Juanhong Zhang2, Jing Ma1
1School of Pharmacy, and State Key Laboratory of Applied Organic Chemistry, Lanzhou 730000, China.
International Journal of Pharmaceutics
|February 4, 2024
Summary
Three-dimensional (3D) printing revolutionizes pharmaceutical development, enabling personalized drug delivery. This technology offers precise pediatric formulations and complex combination therapies, paving the way for clinical implementation.
Area of Science:
- Pharmaceutical Sciences
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Three-dimensional (3D) printing technology offers significant advantages in pharmaceutical development, particularly for personalized drug formulations.
- The U.S. Food and Drug Administration (FDA) approval of 3D-printed drugs has accelerated the adoption of personalized drug delivery systems.
- 3D printing technology is adept at meeting the specific dosage requirements for pediatric patients and managing complex multi-drug combinations.
Approach:
- This review focuses on the application of 3D printing in pediatric pharmaceutical preparations.
- It examines the fundamental principles, benefits, and drawbacks of utilizing 3D printing for pediatric drug formulations.
- The review compiles and evaluates various applications and refined formulations for pediatric use.
Key Points:
- 3D printing enables precise control over drug dosage forms, crucial for pediatric populations.
- The technology facilitates the creation of customized drug combinations, addressing complex treatment regimens.
- Personalized pediatric drug delivery is enhanced through the adaptability of 3D printing.
- The review discusses both the advantages and disadvantages of 3D printing in pediatric applications.
Conclusions:
- 3D printing technology holds substantial promise for advancing personalized drug delivery in pediatric care.
- The review provides a theoretical foundation for implementing 3D printing in clinical pediatric settings.
- Further research and clinical trials are encouraged to fully realize the potential of 3D-printed medications for children.
Related Concept Videos
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

